首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1370351

气喘治疗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2023-2028 年市场概况：

2022年全球气喘治疗市场规模达181亿美元。展望未来，IMARC集团预计到2028年市场规模将达到206亿美元，2023-2028年复合年增长率（CAGR）为2.34%。

气喘治疗药物是指用于治疗气喘的各种药物。气喘通常由室内和室外致病因素引发，包括污染、过敏原和灰尘。这些治疗药物通常是支气管扩张剂和抗发炎药，包括皮质类固醇、长效β受体激动剂（LABA）、甲基黄嘌呤、免疫调节剂和白三烯调节剂。也使用许多可以吸入、注射或口服给药的合併治疗药物。这些药物可扩张进入肺部的通道，并使空气流动以改善呼吸。它们还有助于清除肺部的黏液，从而轻鬆咳出。

气喘治疗市场趋势：

气喘和其他呼吸系统疾病的盛行率不断上升，以及诊断技术的改进，是推动市场成长的关键因素之一。此外，大众对有效气喘治疗方法的认识不断提高也推动了市场的成长。例如，气喘患者主要使用吸入性皮质类固醇进行治疗，晚期或持续性气喘患者则使用针对特定目标的药物进行治疗。对阻断免疫球蛋白 E 和特定细胞因子的单株抗体 (mAb) 也有广泛的需求。用于治疗呼吸系统疾病的联合疗法的发展是另一个生长诱导因素。医疗保健支出的增加、医学领域广泛的研究和开发（R＆D）活动以及医疗保健基础设施的改善是预计进一步推动市场的其他因素。

本报告回答的关键问题

2022 年全球气喘治疗市场规模有多大？
2023-2028年全球气喘治疗市场的预期成长率是多少？
推动全球气喘治疗市场的关键因素是什么？
COVID-19 对全球气喘治疗市场有何影响？
根据药物类别，全球气喘治疗市场的细分如何？
根据产品类型，全球气喘治疗市场的细分如何？
根据治疗类型，全球气喘治疗市场的细分如何？
根据给药途径，全球气喘治疗市场的细分如何？
全球气喘治疗市场的关键地区有哪些？
谁是全球气喘治疗市场的主要参与者/公司？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太地区
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- AstraZeneca PLC
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Novartis International AG
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.

简介目录图表

Product Code: SR112023A2338

Abstract

Market Overview 2023-2028:

The global asthma therapeutics market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2028, exhibiting a growth rate (CAGR) of 2.34% during 2023-2028.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs

Bronchodilators

Combination Therapies

Breakup by Product Type:

Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

Soft Mist Inhalers

Nebulizers

Pneumatic Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Treatment Type:

Quick-Relief Medications

Long-Term Asthma Control Medications

Breakup by Route of Administration:

Inhalation

Oral

Parenteral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global asthma therapeutics market in 2022?
2. What is the expected growth rate of the global asthma therapeutics market during 2023-2028?
3. What are the key factors driving the global asthma therapeutics market?
4. What has been the impact of COVID-19 on the global asthma therapeutics market?
5. What is the breakup of the global asthma therapeutics market based on the drug class?
6. What is the breakup of the global asthma therapeutics market based on the product type?
7. What is the breakup of the global asthma therapeutics market based on the treatment type?
8. What is the breakup of the global asthma therapeutics market based on the route of administration?
9. What are the key regions in the global asthma therapeutics market?
10. Who are the key players/companies in the global asthma therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Anti-Inflammatory Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Bronchodilators
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Combination Therapies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product Type

7.1 Inhalers
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Dry Powder Inhalers
  - 7.1.2.2 Metered Dose Inhalers
  - 7.1.2.3 Soft Mist Inhalers
- 7.1.3 Market Forecast
7.2 Nebulizers
- 7.2.1 Market Trends
- 7.2.2 Major Types
  - 7.2.2.1 Pneumatic Nebulizers
  - 7.2.2.2 Ultrasonic Nebulizers
  - 7.2.2.3 Mesh Nebulizers
- 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

8.1 Quick-Relief Medications
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

9.1 Inhalation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Parenteral
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 AstraZeneca PLC
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Amgen Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biogen Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Boehringer Ingelheim International GmbH
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 F. Hoffmann-La Roche Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 SWOT Analysis
- 15.3.7 GlaxoSmithKline Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Merck Sharp & Dohme Corp.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Novartis International AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sunovion Pharmaceuticals Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 SWOT Analysis
- 15.3.11 Teva Pharmaceutical Industries Ltd.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219